Similar articles for PMID: 16997417

Year	Number of Results
1947	1
1983	1
1987	1
1990	1
1996	2
1997	1
1998	1
2000	1
2001	1
2003	1
2004	2
2005	6
2006	18
2007	21
2008	14
2009	14
2010	4
2011	4
2012	3
2013	3
2014	3
2015	4
2016	3
2017	2
2018	1
2019	2
2021	2
2022	0

1

Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway.

Bitonti AJ, Dumont JA. Bitonti AJ, et al. Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1106-18. doi: 10.1016/j.addr.2006.07.015. Epub 2006 Aug 12. Adv Drug Deliv Rev. 2006. PMID: 16997417 Review.

2

Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis.

Low SC, Nunes SL, Bitonti AJ, Dumont JA. Low SC, et al. Hum Reprod. 2005 Jul;20(7):1805-13. doi: 10.1093/humrep/deh896. Epub 2005 Apr 7. Hum Reprod. 2005. PMID: 15817590

3

Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.

Suzuki T, Ishii-Watabe A, Tada M, Kobayashi T, Kanayasu-Toyoda T, Kawanishi T, Yamaguchi T. Suzuki T, et al. J Immunol. 2010 Feb 15;184(4):1968-76. doi: 10.4049/jimmunol.0903296. Epub 2010 Jan 18. J Immunol. 2010. PMID: 20083659 Free article.

4

Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway.

Dumont JA, Bitonti AJ, Clark D, Evans S, Pickford M, Newman SP. Dumont JA, et al. J Aerosol Med. 2005 Fall;18(3):294-303. doi: 10.1089/jam.2005.18.294. J Aerosol Med. 2005. PMID: 16181004 Clinical Trial.

5

Monomeric Fc fusions: impact on pharmacokinetic and biological activity of protein therapeutics.

Dumont JA, Low SC, Peters RT, Bitonti AJ. Dumont JA, et al. BioDrugs. 2006;20(3):151-60. doi: 10.2165/00063030-200620030-00002. BioDrugs. 2006. PMID: 16724863 Review.

6

Clinical perspectives on pulmonary systemic and macromolecular delivery.

Scheuch G, Kohlhaeufl MJ, Brand P, Siekmeier R. Scheuch G, et al. Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):996-1008. doi: 10.1016/j.addr.2006.07.009. Epub 2006 Aug 12. Adv Drug Deliv Rev. 2006. PMID: 16996638 Review.

7

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway.

Bitonti AJ, Dumont JA, Low SC, Peters RT, Kropp KE, Palombella VJ, Stattel JM, Lu Y, Tan CA, Song JJ, Garcia AM, Simister NE, Spiekermann GM, Lencer WI, Blumberg RS. Bitonti AJ, et al. Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9763-8. doi: 10.1073/pnas.0403235101. Epub 2004 Jun 21. Proc Natl Acad Sci U S A. 2004. PMID: 15210944 Free PMC article.

8

Expression and characterization of human growth hormone-Fc fusion proteins for transcytosis induction.

Lee CH, Woo JH, Cho KK, Kang SH, Kang SK, Choi YJ. Lee CH, et al. Biotechnol Appl Biochem. 2007 Apr;46(Pt 4):211-7. doi: 10.1042/BA20060083. Biotechnol Appl Biochem. 2007. PMID: 17067288

9

Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.

Huang C. Huang C. Curr Opin Biotechnol. 2009 Dec;20(6):692-9. doi: 10.1016/j.copbio.2009.10.010. Epub 2009 Nov 4. Curr Opin Biotechnol. 2009. PMID: 19889530 Review.

10

In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.

Sakagami M. Sakagami M. Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1030-60. doi: 10.1016/j.addr.2006.07.012. Epub 2006 Aug 15. Adv Drug Deliv Rev. 2006. PMID: 17010473 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed